Drug profile · INN
mebendazole
PHARMACY ACTION WORM TREATMENT
mebendazole (PHARMACY ACTION WORM TREATMENT) is a tubulin inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — mebendazole
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
mebendazole (PHARMACY ACTION WORM TREATMENT) is a tubulin inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Tubulin inhibitor
Primary target: Tubulin
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is mebendazole?
mebendazole (PHARMACY ACTION WORM TREATMENT) is a tubulin inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for mebendazole?
PHARMACY ACTION WORM TREATMENT is a marketed brand name for mebendazole. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mebendazole?
mebendazole has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.